Min Cui
Dr. Min Cui is the Founding Partner and Managing Director of Decheng Capital. Prior to founding Decheng Capital in 2011, Dr. Cui was an Investment Partner at Bay City Capital, a leading international life science venture capital firm, and focused on evaluating investment opportunities as well as its initiatives in China. Dr. Cui is a member of the board of directors of GeneWeave Biosciences, GenturaDx and Shenzhen GeneMDx Biotechnology. His investment portfolio also includes Ion Torrent Systems (acquired by Life technologies for $725M), China Biologic Products (NASDAQ: CBPO), Epizyme, and Sunesis (NASDAQ: SNSS).